Advertisement
Advertisement
Coronavirus pandemic
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
University student Wan Ruyi, 21, has acute leukaemia and urgently needs a bone-marrow transplant. Photo: Weibo

As coronavirus cases get priority in Wuhan hospitals, other patients are losing hope

  • Thousands of people are not getting the treatment they need because medical resources have been diverted to fight outbreak
  • One hospital says it can no longer offer transplant surgery as it doesn’t have enough doctors and blood products
In the packed hospitals of Wuhan, coronavirus patients are struggling to get treatment. But for those in the outbreak epicentre who do not have the potentially deadly new illness, the situation could be even worse.

University student Wan Ruyi was diagnosed with acute leukaemia in May. The 21-year-old has been in the Wuhan Union Hospital for the past 10 months, and now, severely ill, she is in dire need of a bone-marrow transplant.

“Wan has had three rounds of chemotherapy, but the last one in October wasn’t very successful, and the bone marrow aspiration she had on Sunday showed the treatment didn’t have the expected outcome,” said her mother, Wu Qiong.

Wuhan Union Hospital was one of the first designated to treat coronavirus patients, on January 21. It told the family it had stopped doing transplant surgery because there were not enough doctors and blood products. The family tried a hospital in Hebei province, but they were told to stay in Wuhan.

On Sunday, Wan was in so much pain and discomfort she said she wanted to die.

“Every single day in Hubei [province] makes me more helpless and desperate as my daughter continues to suffer in agony,” Wu said. “Her condition is getting more unstable.”

Wan is among thousands of patients in urgent need of treatment in Wuhan who are not getting it because medical resources have been diverted to fight the coronavirus outbreak. They include people with cancer and conditions like bronchial asthma and epilepsy. Some of these desperate patients have been posting messages on Weibo, China’s Twitter, seeking help from elsewhere in the country.
Chinese authorities have taken unprecedented measures to contain the outbreak that began in December, including locking down Wuhan and at least 15 other cities in Hubei province for weeks, affecting more than 50 million people.
In Wuhan, two temporary hospitals have been built from scratch in less than two weeks to cope with the crisis, and other makeshift medical facilities are also treating patients. But the number infected with the pneumonia-like illness continues to climb, and it has killed more than 1,000 people. By Monday there were nearly 32,000 coronavirus patients in Hubei province alone, and more than 18,000 of them were in Wuhan.

For 81-year-old Fu Daoshun, the outbreak means he can no longer receive the daily injection he needs to treat deep-vein thrombosis in his legs. He used to have this done at the Puai Hospital, but it too was designated as a centre for treating coronavirus cases, from January 23, and no longer has the resources to treat patients like Fu.

His granddaughter, Fu Yufen, said all he can do now is stay in bed.

“It’s too painful for him to walk after going days without the injections to ease the pain, and now it’s too dangerous for him to go to the hospital anyway because he could easily get the virus,” she said.

“And because the city’s in lockdown, we can’t visit. So my grandma, who’s also very old, has to look after him on her own. I’m really worried that they will fall ill.”

Fu Yufen said her grandparents were receiving grocery deliveries from community officers, but she was worried about how long they would be able to manage, adding that her grandfather had written a will last week.

Medical workers in protective suits attend to a coronavirus patient at a designated hospital in Wuhan. Photo: Reuters

Health experts said although coronavirus patients had been given priority, people with other chronic and acute diseases also needed support.

Tang Shenlan, a professor with the Department of Population Health Science at the Duke University School of Medicine and deputy director of the Duke Global Health Institute in the US, said it was wrong to put all the focus on coronavirus cases, and not helpful for people with other serious illnesses.

“Hospitals in Wuhan should find an innovative way to provide essential services to these patients – for example using telemedicine [to treat and diagnose remotely] including prescriptions,” he said.

Tang said while there had been progress since the health care system reform began in 2009, with more people now covered by health insurance, “reforming public hospitals in China has failed”.

“China needs a revolution, not a reform, of its health care system – including clinical and public health service financing and provision,” said Tang, who drafted the World Health Organisation proposal for reform of China’s health care system as a senior adviser to the WHO more than a decade ago.

Yao Zelin, a sociology professor focusing on health care at East China Normal University in Shanghai, said the medical system needed to be improved at the grass-roots level.

“China has emphasised the build-up of big hospitals but not the network of clinics, which means that during an emergency like the coronavirus outbreak, only the big hospitals can be used to tackle the epidemic, and the surge of patients quickly takes up all the resources,” Yao said.

Coronavirus: heads roll in Hubei as Beijing axes health officials

Gregory Gray, a professor specialising in infectious diseases at Duke University’s Global Health Institute, said China also needed to better anticipate emerging virus threats so it could respond to them earlier.

“One way to do so is to encourage ‘one health’ oriented studies at the places where humans and animals mix like live animal markets and domestic animal farms,” Gray said. “We need to find ways to work more closely together – human health, animal health, environmental health and agriculture industries.”

Purchase the China AI Report 2020 brought to you by SCMP Research and enjoy a 20% discount (original price US$400). This 60-page all new intelligence report gives you first-hand insights and analysis into the latest industry developments and intelligence about China AI. Get exclusive access to our webinars for continuous learning, and interact with China AI executives in live Q&A. Offer valid until 31 March 2020.
Post